Myocarditis epidemiology: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
It is generally due to [[viral infections]] such as [[adenovirus]], [[parvovirus B19]], [[hepatitis C]], and [[herpes virus 6]] in developed countries and [[HIV]], [[rheumatic disease]] in developing countries.
===Developed Countries===
Myocarditis is generally due to [[viral infections]] such as [[adenovirus]], [[parvovirus B19]], [[hepatitis C]], and [[herpes virus 6]] in developed countries.
===Developing Countries===
Myocarditis is generally due to [[HIV]] and [[rheumatic heart disease]] in developing countries.


==Developed countries==
==Developed countries==
Line 29: Line 32:
[[Category:Up to date cardiology]]
[[Category:Up to date cardiology]]
[[Category:Overview complete]]
[[Category:Overview complete]]
 
[[Category:Epidemiology]]
{{WH}}
{{WH}}


{{WS}}
{{WS}}

Revision as of 21:52, 4 September 2011

Myocarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Adrenergic Myocarditis
Giant Cell Myocarditis

Causes

Differentiating Myocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myocarditis epidemiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Myocarditis epidemiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myocarditis epidemiology

CDC on Myocarditis epidemiology

Myocarditis epidemiology in the news

Blogs on Myocarditis epidemiology

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myocarditis epidemiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Varun Kumar, M.B.B.S.; Cafer Zorkun, M.D., Ph.D. [2]

Overview

Developed Countries

Myocarditis is generally due to viral infections such as adenovirus, parvovirus B19, hepatitis C, and herpes virus 6 in developed countries.

Developing Countries

Myocarditis is generally due to HIV and rheumatic heart disease in developing countries.

Developed countries

Viral infections are the common cause for myocarditis in developed countries. Common virus involved are coxsackie B, . An article from 1995 reports that in Sweden the frequency of dilated cardiomyopathy secondary to myocarditis 7.5-10% per 100,000 annually with enteroviruses, and particularly the Coxsackie-B viruses being the most common cause[1]. Recent studies show that adenovirus, parvovirus B19, hepatitis C, and herpes virus 6 were the common causes for myocarditis[2][3].

The exact incidence of myocarditis is unknown. However, in series of routine autopsies, 1-9% of all patients had evidence of myocardial inflammation. In young adults, up to 20% of all cases of sudden death are due to myocarditis.

Myocarditis secondary to lyme disease should be suspected in people travelling to regions where it is endemic, particularly if they have conduction abnormalities of heart[4].

Developing countries

In South America, Chagas' disease (caused by Trypanosoma cruzi) is the main cause of myocarditis. Other causes in developing countries include rheumatic fever[5] and HIV infection.

Race

No difference in frequency of myocarditis is observed between various races.

The impact of Gender

Myocarditis is slightly more frequent among males than in females[6]. This may be due to natural hormonal protection among females.

References

  1. Friman G, Wesslén L, Fohlman J, Karjalainen J, Rolf C (1995). "The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy". Eur Heart J. 16 Suppl O: 36–41. PMID 8682098.
  2. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T; et al. (2008). "Predictors of outcome in patients with suspected myocarditis". Circulation. 118 (6): 639–48. doi:10.1161/CIRCULATIONAHA.108.769489. PMID 18645053.
  3. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D; et al. (2005). "High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction". Circulation. 111 (7): 887–93. doi:10.1161/01.CIR.0000155616.07901.35. PMID 15699250.
  4. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S (1989). "Lyme carditis: an important cause of reversible heart block". Ann Intern Med. 110 (5): 339–45. PMID 2644885.
  5. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005). "The global burden of group A streptococcal diseases". Lancet Infect Dis. 5 (11): 685–94. doi:10.1016/S1473-3099(05)70267-X. PMID 16253886.
  6. Schwartz J, Sartini D, Huber S (2004). "Myocarditis susceptibility in female mice depends upon ovarian cycle phase at infection". Virology. 330 (1): 16–23. doi:10.1016/j.virol.2004.06.051. PMID 15527830.

Template:WH

Template:WS